The study aims to find biomarkers in idiopathic pulmonary fibrosis (IPF) that can predict adverse outcomes and help monitor disease progression over time.
Researchers used data from two groups of IPF patients and analyzed CT imaging biomarkers to assess disease severity and their relationship with lung function and survival.
The weighted reticulovascular score (WRVS) showed significant potential as a predictive tool, with a baseline score of ≥15% indicating a higher risk of mortality and an increase of 3% in WRVS correlating with reduced survival, surpassing traditional visual assessments of fibrosis.